Medicus Pharma (NASDAQ:MDCX – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Stock Down 5.2 %
NASDAQ:MDCX opened at $3.13 on Friday. Medicus Pharma has a 52 week low of $1.80 and a 52 week high of $6.00. The company has a 50-day moving average price of $3.21.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on MDCX. Maxim Group started coverage on Medicus Pharma in a research report on Tuesday, December 17th. They set a “buy” rating and a $10.00 target price on the stock. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd.
About Medicus Pharma
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Read More
- Five stocks we like better than Medicus Pharma
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 03/24 – 03/28
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- With Risk Tolerance, One Size Does Not Fit All
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
